Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateBusiness Wire • 02/29/24
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanBusiness Wire • 02/27/24
Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in JapanBusiness Wire • 02/26/24
Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesBusiness Wire • 02/21/24
Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 01/15/24
Akili Reports Third Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 11/09/23
Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ETBusiness Wire • 10/19/23
Employees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study FindsBusiness Wire • 10/12/23
Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHDBusiness Wire • 09/21/23
Akili Reports Second Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 08/10/23
Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ETBusiness Wire • 07/10/23
Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHDBusiness Wire • 06/07/23
Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych CongressBusiness Wire • 05/31/23
Akili Reports First Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 05/11/23
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili's EndeavorRx® Video Game-Based TherapeuticBusiness Wire • 05/04/23
Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili's EndeavorRx® Video Game-Based TherapeuticBusiness Wire • 05/03/23
Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ETBusiness Wire • 04/13/23